HeartBeam is a medical technology company primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. Co.'s initial focus is providing diagnostic data to help physicians with care management of patients with cardiovascular disease. Co. is developing its telehealth Product to address the field of remote patient monitoring. Co.'s telehealth Product is comprised of a credit card sized ECG machine and a cloud-based diagnostic software exert system. Co. is applying its platform technology to create a software tool for detecting heart attacks in the Emergency Room environment. The BEAT average annual return since 2021 is shown above.
The Average Annual Return on the BEAT average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether BEAT average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the BEAT average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|